ITGAL and gastric cancer: Specifically, increased ITGAL mRNA expression was associated with poorer OS and PPS in stage 1 (OS HR = 0.22, p = 0.0062) and stage 2 (OS HR = 2.18, p = 0.022; PPS HR = 3.58, p = 0.00016) of GC patients (Table 1).